Four PTEN-targeting co-expressed miRNAs and ACTN4-targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue

被引:26
作者
Berania, Ilyes [1 ,2 ,3 ]
Cardin, Guillaume B. [1 ,2 ]
Clement, Isabelle [1 ,2 ]
Guertin, Louis [3 ]
Ayad, Tareck [3 ]
Bissada, Eric [3 ]
Phuc Felix Nguyen-Tan [4 ]
Filion, Edith [4 ]
Guilmette, Julie [5 ,6 ]
Gologan, Olguta [5 ]
Soulieres, Denis [7 ]
Rodier, Francis [1 ,2 ,8 ]
Wong, Philip [1 ,2 ,4 ]
Christopoulos, Apostolos [1 ,2 ,3 ]
机构
[1] CRCHUM, Montreal, PQ, Canada
[2] Inst Canc Montreal, Montreal, PQ, Canada
[3] Ctr Hosp Univ Montreal, Otolaryngol Head & Neck Surg Serv, Montreal, PQ, Canada
[4] Ctr Hosp Univ Montreal, Dept Radiat Oncol, Montreal, PQ, Canada
[5] Ctr Hosp Univ Montreal, Dept Pathol, Montreal, PQ, Canada
[6] Massachusetts Gen Hosp, Dept Pathol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[7] Ctr Hosp Univ Montreal, Dept Med, Serv Hematooncol, Montreal, PQ, Canada
[8] Univ Montreal, Dept Radiol Radiooncol & Med Nucl, Montreal, PQ, Canada
关键词
tongue; miRNA; PTEN; ACTN4; PI3K; NASOPHARYNGEAL CARCINOMA; COLORECTAL-CANCER; HEAD; EXPRESSION; NECK; AXL; METASTASIS; RESISTANCE; PROMOTES; EVEROLIMUS;
D O I
10.1002/ijc.30915
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to determine the prognostic value and oncogenic pathways associated to miRNA expression in squamous cell carcinoma of the oral tongue and to link these miRNA candidates with potential gene targets. We performed a miRNA screening within our institutional cohort (n=58 patients) and reported five prognostic targets including a cluster of four co-expressed miRNAs (miR-18a, miR-92a, miR-103, and miR-205). Multivariate analysis showed that expression of miR-548b (p=0.007) and miR-18a (p=0.004, representative of co-expressed miRNAs) are independent prognostic markers for squamous cell carcinoma of the oral tongue. These findings were validated in The Cancer Genome Atlas ( TCGA) cohort (n=131) for both miRNAs (miR-548b: p=0.027; miR-18a: p=0.001). Bioinformatics analysis identified PTEN and ACTN4 as direct targets of the four co-expressed miRNAs and miR-548b, respectively. Correlations between the five identified miRNAs and their respective targeted genes were validated in the two merged cohorts and were concordantly significant (miR-18a/PTEN: p < 0.0001; miR-92a/PTEN: p=0.0008; miR-103/PTEN: p=0.008; miR-203/PTEN: p=0.019; miR-548b/ACTN4: p=0.009).
引用
收藏
页码:2318 / 2328
页数:11
相关论文
共 51 条
[11]   miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes [J].
Dweep, Harsh ;
Sticht, Carsten ;
Pandey, Priyanka ;
Gretz, Norbert .
JOURNAL OF BIOMEDICAL INFORMATICS, 2011, 44 (05) :839-847
[12]   AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas [J].
Elkabets, Moshe ;
Pazarentzos, Evangelos ;
Juric, Dejan ;
Sheng, Qing ;
Pelossof, Raphael A. ;
Brook, Samuel ;
Benzaken, Ana Oaknin ;
Rodon, Jordi ;
Morse, Natasha ;
Yan, Jenny Jiacheng ;
Liu, Manway ;
Das, Rita ;
Chen, Yan ;
Tam, Angela ;
Wang, Huiqin ;
Liang, Jinsheng ;
Gurski, Joseph M. ;
Kerr, Darcy A. ;
Rosell, Rafael ;
Teixido, Cristina ;
Huang, Alan ;
Ghossein, Ronald A. ;
Rosen, Neal ;
Bivona, Trever G. ;
Scaltriti, Maurizio ;
Baselga, Jose .
CANCER CELL, 2015, 27 (04) :533-546
[13]   Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis [J].
Estilo, Cherry L. ;
O-charoenrat, Pornchai ;
Talbot, Simon ;
Socci, Nicholas D. ;
Carlson, Diane L. ;
Ghossein, Ronald ;
Williams, Tijaana ;
Yonekawa, Yoshihiro ;
Ramanathan, Yegnanarayana ;
Boyle, Jay O. ;
Kraus, Dennis H. ;
Patel, Snehal ;
Shaha, Ashok R. ;
Wong, Richard J. ;
Huryn, Joseph M. ;
Shah, Jatin P. ;
Singh, Bhuvanesh .
BMC CANCER, 2009, 9
[14]   A gene expression profile for non-smoking and non-drinking patients with head and neck cancer [J].
Farshadpour, F. ;
Roepman, P. ;
Hordijk, G. J. ;
Koole, R. ;
Slootweg, P. J. .
ORAL DISEASES, 2012, 18 (02) :178-183
[15]   Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J].
Ferris, R. L. ;
Blumenschein, G., Jr. ;
Fayette, J. ;
Guigay, J. ;
Colevas, A. D. ;
Licitra, L. ;
Harrington, K. ;
Kasper, S. ;
Vokes, E. E. ;
Even, C. ;
Worden, F. ;
Saba, N. F. ;
Iglesias Docampo, L. C. ;
Haddad, R. ;
Rordorf, T. ;
Kiyota, N. ;
Tahara, M. ;
Monga, M. ;
Lynch, M. ;
Geese, W. J. ;
Kopit, J. ;
Shaw, J. W. ;
Gillison, M. L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1856-1867
[16]   IMPROVED SURVIVAL IN THE TREATMENT OF SQUAMOUS CARCINOMA OF THE ORAL TONGUE [J].
FRANCESCHI, D ;
GUPTA, R ;
SPIRO, RH ;
SHAH, JP .
AMERICAN JOURNAL OF SURGERY, 1993, 166 (04) :360-365
[17]   Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal [J].
Gao, Jianjiong ;
Aksoy, Buelent Arman ;
Dogrusoz, Ugur ;
Dresdner, Gideon ;
Gross, Benjamin ;
Sumer, S. Onur ;
Sun, Yichao ;
Jacobsen, Anders ;
Sinha, Rileen ;
Larsson, Erik ;
Cerami, Ethan ;
Sander, Chris ;
Schultz, Nikolaus .
SCIENCE SIGNALING, 2013, 6 (269) :pl1
[18]   MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN [J].
Geng, Li ;
Sun, Bing ;
Gao, Bo ;
Wang, Zheng ;
Quan, Cheng ;
Wei, Feng ;
Fang, Xue-Dong .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (05) :8458-8472
[19]   Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib [J].
Giles, Keith M. ;
Kalinowski, Felicity C. ;
Candy, Patrick A. ;
Epis, Michael R. ;
Zhang, Priscilla M. ;
Redfern, Andrew D. ;
Stuart, Lisa M. ;
Goodall, Gregory J. ;
Leedman, Peter J. .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) :2541-2558
[20]   Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation [J].
Hall, J. S. ;
Taylor, J. ;
Valentine, H. R. ;
Irlam, J. J. ;
Eustace, A. ;
Hoskin, P. J. ;
Miller, C. J. ;
West, C. M. L. .
BRITISH JOURNAL OF CANCER, 2012, 107 (04) :684-694